3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
8
Colorectal Neoplasms
7
Prostatic Neoplasms
6
Stomach Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
5
Pancreatic Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity
2
Meningioma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Surgical Wound Dehiscence
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Small Cell Lung Carcinoma
1
Skull Base Neoplasms
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Interventions
Carboplatin
5
Nivolumab
4
pembrolizumab
3
Pemetrexed
3
Ipilimumab
3
fludarabine
2
atezolizumab
2
Cyclophosphamide
2
Cisplatin
2
tremelimumab
1
sotorasib
1
osimertinib
1
olaparib
1
durvalumab
1
Tumor Burden
1
Thoracoscopy
1
Tablets
1
Saline Solution
1
Quality of Life
1
Observation
1
Magnesium Sulfate
1
Injections
1
Influenza Vaccines
1
Histocompatibility Testing
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Exercise Therapy
1
Combined Modality Therapy
1
Cell- and Tissue-Based Therapy
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mesothelioma
×
Observation
×
Clear all
NCT02073500
2021-07-28
PSM
Oslo University Hospital
Recruiting
300 enrolled